LH Laboratory Corp Of America Holdings

Price (delayed)

$271.6

Market cap

$26.18B

P/E Ratio

9.19

Dividend/share

N/A

EPS

$29.54

Enterprise value

$30.58B

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights
The gross profit has surged by 102% year-on-year and by 9% since the previous quarter
The quick ratio has soared by 98% YoY and by 27% from the previous quarter

Key stats

What are the main financial stats of LH
Market
Shares outstanding
96.4M
Market cap
$26.18B
Enterprise value
$30.58B
Valuations
Price to earnings (P/E)
9.19
Price to book (P/B)
2.59
Price to sales (P/S)
1.62
EV/EBIT
7.48
EV/EBITDA
6.13
EV/Sales
1.87
Earnings
Revenue
$16.39B
EBIT
$4.09B
EBITDA
$4.99B
Free cash flow
$2.84B
Per share
EPS
$29.54
Free cash flow per share
$29.03
Book value per share
$104.86
Revenue per share
$167.74
TBVPS
$91.29
Balance sheet
Total assets
$20.42B
Total liabilities
$10.15B
Debt
$6.36B
Equity
$10.25B
Working capital
$3.03B
Liquidity
Debt to equity
0.62
Current ratio
2.13
Quick ratio
1.8
Net debt/EBITDA
0.88
Margins
EBITDA margin
30.4%
Gross margin
38.6%
Net margin
17.6%
Operating margin
25%
Efficiency
Return on assets
14.5%
Return on equity
30.4%
Return on invested capital
39.4%
Return on capital employed
23%
Return on sales
24.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
-1.49%
1 week
-2.42%
1 month
-9.38%
1 year
40.92%
YTD
33.43%
QTD
-3.5%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$16.39B
Gross profit
$6.33B
Operating income
$4.1B
Net income
$2.88B
Gross margin
38.6%
Net margin
17.6%
The gross profit has surged by 102% year-on-year and by 9% since the previous quarter
LH's revenue is up by 43% year-on-year and by 7% since the previous quarter
The gross margin has grown by 42% YoY
Laboratory Corp Of America Holdings's operating income has increased by 11% QoQ

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
9.19
P/B
2.59
P/S
1.62
EV/EBIT
7.48
EV/EBITDA
6.13
EV/Sales
1.87
The price to earnings (P/E) is 52% lower than the 5-year quarterly average of 19.3 and 31% lower than the last 4 quarters average of 13.3
Laboratory Corp Of America Holdings's EPS has increased by 9% QoQ
The company's equity rose by 39% YoY and by 2.2% QoQ
The P/B is 13% higher than the 5-year quarterly average of 2.3 and 8% higher than the last 4 quarters average of 2.4
LH's revenue is up by 43% year-on-year and by 7% since the previous quarter
LH's price to sales (P/S) is 8% higher than its 5-year quarterly average of 1.5 and 8% higher than its last 4 quarters average of 1.5

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
The company's return on invested capital rose by 9% QoQ
LH's ROA is up by 6% QoQ
Laboratory Corp Of America Holdings's return on sales has increased by 2.9% QoQ

Dividends

What is LH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LH.

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 101% greater than its total liabilities
The quick ratio has soared by 98% YoY and by 27% from the previous quarter
Laboratory Corp Of America Holdings's current ratio has soared by 90% YoY and by 28% from the previous quarter
The debt is 38% smaller than the equity
The company's equity rose by 39% YoY and by 2.2% QoQ
LH's debt to equity is down by 36% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.